Technical testing and analysis
ONCOGENE AS
Revenue 2024
NOK 644,000
Operating profit
NOK 201,000
Equity
NOK 1.1m
Incorporated
2020
Share capital
NOK 32,000
Key figures · 2024
Current ratio
0.43
Equity ratio
14.6%
Key figures over time · 2024
| Key figures | 2024 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | 31.2% | |
| Net margin (%%) | 8.9% | |
| Return on assets (%%) | 2.7% | |
| Likviditet | ||
| Current ratio | 0.43 | |
| Working capital | −3.6m | |
| Soliditet | ||
| Equity ratio (%%) | 14.6% | |
| Debt-to-equity ratio | 5.83 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.